ArticleMikrochimica acta2026
3D alginate hydrogel microspheres with uniform micro-structure for cell culture and CVB3 infection.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
An integrated microfluidic platform has been developed for the efficient generation of highly uniform alginate hydrogel microspheres (AHMs) encapsulating HeLa cells, enabling robust three dimensional (3D) cell culture and subsequent infection with Coxsackievirus B3 expressing enhanced green fluorescent protein (CVB3-eGFP). Our results demonstrate that AHMs support high cell viability and facilitated cell proliferation within a biomimetic 3D matrix. By systematically reducing the alginate concentration from 1.0% to 0.6%, we enhanced viral accessibility while maintaining microstructural integrity, thereby significantly improving CVB3-eGFP infection rates, as confirmed by fluorescence imaging and western blot analysis. This study establishes a tunable, reproducible, and physiologically relevant 3D model for studying virus-host interactions, with broad applications in antiviral drug screening and infectious disease modeling.
Indexed as
Identifiers
41665724What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.